![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
SGLT2 Inhibitors: CV Outcomes Data in Type 2 Diabetes (HCPLive) View |
![]() |
SGLT2 inhibitors and cardiovascular outcomes in type 2 diabetes: VERTIS CV trial (GPnotebook) View |
![]() |
Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors (Radcliffe Cardiology) View |
![]() |
SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes (AJMCtv MJH) View |
![]() |
CV Risk in T2D: Role of SGLT2 Inhibition (HCPLive) View |
![]() |
Using SGLT2-inhibitors to treat cardiac patients with diabetes (Ted Rogers Centre for Heart Research) View |
![]() |
GLP-1 Agonists: CV Outcomes Data in Type 2 Diabetes (HCPLive) View |
![]() |
Update on SGLT-2 inhibitors (ADA 2021) (GoggleDocs Education) View |
![]() |
Fundamentals of SGLT2i's and GLP-1RA's for CV Risk (American College of Cardiology) View |
![]() |
Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM (PeerView CME) View |